March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Royal jelly Peptide Promotes Retinal Ganglion Cell Survival in Experimental Model of Glaucoma Through Up-regulating BDNF and GDNF
Author Affiliations & Notes
  • Jihong Wu
    Eye & ENT Hospital, Fudan University, Shanghai, China
  • Xinghuai Sun
    Eye & ENT Hospital, Fudan University, Shanghai, China
  • Shenghai Zhang
    Eye & ENT Hospital, Fudan University, Shanghai, China
  • Footnotes
    Commercial Relationships  Jihong Wu, None; Xinghuai Sun, None; Shenghai Zhang, None
  • Footnotes
    Support  Chinese National Science Foundation(81070726)
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6581. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jihong Wu, Xinghuai Sun, Shenghai Zhang; Royal jelly Peptide Promotes Retinal Ganglion Cell Survival in Experimental Model of Glaucoma Through Up-regulating BDNF and GDNF. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6581.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Royal jelly (RJ), which is fed to the queen honey-bee, has been reported to possess variety of biological activities toward various types of cells and tissues. Increasing evidence recently suggests that RJ may induce neurite outgrowth and play neuroprotective roles in the adult brain. However, nothing is known about its effect on retinal ganglion cell (RGC). This study examined whether Royal jelly peptide (RJP) prevents RGCs loss in an experimental model of glaucoma.

Methods: : Intraocular pressure (IOP) elevation in adult male Norwegian Brown rats was induced by anterior chamber injection of paramagnetic polystyrene microspheres. Soluble RJP were intravitreally injected to examine its effects on RGC survival after ocular hypertension by the counting of retrograde FG-labeled RGCs. The loss of nerve fibers and RGC were also evaluated in paraffin-fixed retinal cross sections. The possible mechanisms of neuroprotective effects mediated by RJP were further characterized by determining BDNF and GDNF expressions in retina using Western blotting and Real-time quantitative PCR, respectively.

Results: : RJP significantly reduced RGC loss 2 and 4 weeks after ocular hypertension. The loss of RGC in PBS-(used as a negative control) and RJP-treated retinas was approximately 34.6% and 19.2% respectively at 4weeks (p<0.01), compared with control. Thus RJP preserved 32.1% of cells that were destined to die in glaucomatous retinas. Western blot and qPCR results showed that RJP obviously up-regulated protein and mRNA expressions of GDNF and BDNF in retinas.

Conclusions: : The present results first demonstrate that RJP treatment reduced the loss of RGC and neurofibers in an experimental model of glaucoma. RJP may exert neuroprotective effects by up-regulating BDNF and GDNF in retina.

Keywords: ganglion cells • neuroprotection • nutritional factors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×